首頁
Paratek Pharmaceuticals

7月 2026Paratek Pharmaceuticals的市場佔有率分析

Peer-reviewed publications and conference presentations from Paratek’s clinical research and medical affairs teams.

健康 > 生物技術和製藥

域名paratekpharma.com

成立年份1996

僱員201 - 500

年度營收$100M - $200M

Paratek Pharmaceuticals

Paratek Pharmaceuticals（包含公司地區）

paratekpharma.com

查看更多網站流量與參與度資訊

Paratek Pharmaceuticals截至 7月 2026 的總收入為 100M - 200M

Paratek Pharmaceuticals 熱門網域產生的總收入

Paratek Pharmaceuticals 熱門網域 3 年內的總收入

Paratek Pharmaceuticals 熱門網域的總收入

paratekpharma.com100M - 200M

透過銷售情報查看更多內容

Paratek Pharmaceuticals的熱門網域總造訪量

了解Paratek Pharmaceuticals市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

paratekpharma.com5.7K

透過銷售情報查看更多內容

Paratek Pharmaceuticals的熱門網域平均造訪時長

分析Paratek Pharmaceuticals參與度指標。

過去 3 個月平均造訪時長

子公司細目

paratekpharma.com00:00:18

透過銷售情報查看更多內容

Paratek Pharmaceuticals的熱門網域平均頁面瀏覽量

了解Paratek Pharmaceuticals如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

paratekpharma.com1.80

透過銷售情報查看更多內容

Paratek Pharmaceuticals按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Paratek Pharmaceuticals

这些是Paratek Pharmaceuticals顶级域名使用的行业网站技术

轉換與分析 (4)

Google Analytics

市場行銷 (3)

Google Marketing Platform

招募 (3)

Greenhouse

電子郵件服務 (2)

Microsoft Exchange Online

更多技術

10

檢視所有

新聞與訊號來自Paratek Pharmaceuticals

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Paratekpharma attended event ESCMID Global 2026 on Apr 17th '21.KING OF PRUSSIA, Pa., April 16, 2026 (GLOBE NEWSWIRE) - Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on high-need, targeted therapeutic areas, today announced that new data from scientific and investigator-initiated studies of NUZYRA(R)(omadacycline) will be presented at ESCMID Global 2026, the annual Congress of the European Society of Clinical Microbiology and Infectious Diseases, taking place in Munich, Germany, April 17-21

新聞Paratekpharma received financing of $50M in investment on Mar 18th '26.BioPharma Credit PLC on Wednesday announced a new $50 million investment in Paratek Pharmaceuticals Inc to fund the completion of the company's combination with Radius Health Inc.

新聞B-FLEXION group acquired Paratekpharma on Jul 1st '23.B-FLEXION acquired Paratek in 2023 and has since positioned the company as a platform for building a diversified specialty portfolio.